Benzinga | Dec 20, 2021 07:10AM EST

Barclays Maintains Overweight on Eli Lilly, Raises Price Target to $325

Barclays analyst Carter Gould maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $280 to $325.